The Biotechnology Research Institute of the National Research Council Canada (NRC-BRI) is the largest Canadian research facility devoted to biotechnology. Located in Montréal, the Institute promotes, assists and conducts leading-edge R&D in the fields of health, bioprocess and environment. Through innovative research achievements, strategic collaborations and technology transfers with the biotechnology industry, BRI has earned an international reputation for expertise, research excellence and technological innovation.

BRI Obtains $1.8 Million for Bioindustrial Reseach The main goal of this research project is to develop industrial uses for agriculture crop residues (fibres and shives), such as in composite materials for the automobile, aircraft and construction sectors, as well as to develop biochemicals as feedstock for the "green chemical" industry. BRI is announcing the 11th edition of the Crossroad of Biotechnology Candida albicans Genome Fully Annotated NRC-BRI has been the coordinating centre for an international group of scientists working on the complete genomic annotation of Candida albicans, a fungal pathogen that is one of the main causes of infection in people with weakened immune systems.